Abraham Winkelstein

Abraham Winkelstein practices at Woodlands Endoscopy Center - HOPD in Shenandoah, Texas.

Abraham Winkelstein's NPI, 1548260920, was assigned on July 27, 2005. Abraham Winkelstein graduated from Georgetown University School Of Medicine in 1991. Abraham Winkelstein's Texas license number on file is K4297.

Abraham Winkelstein's primary practice is Woodlands Endoscopy Center - HOPD, at 111 Vision Park Blvd STE 230, Shenandoah, TX 77384.

Abraham Winkelstein's primary practice is Woodlands Endoscopy Center - HOPD in Shenandoah, Texas. Abraham Winkelstein is also affiliated with Memorial Hermann Greater Heights Hospital. The medical group on file is Digestive Specialists, P.A. Dmand AI also links Abraham Winkelstein to 4 more hospitals, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Abraham Winkelstein practices, 8 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Abraham Winkelstein's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Abraham Winkelstein is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Abraham Winkelstein's licenses on file in 2 states: Texas and California.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver, gastroenteritis, intestinal diverticulosis and intestinal or bowel obstruction among the conditions Abraham Winkelstein treats.

CMS data shows 1,099 Medicare services from Abraham Winkelstein across 10 procedure codes in 2024, for 593 Medicare patients. Medicare paid $109,253 for them.

CMS counts 593 Medicare patients who saw Abraham Winkelstein in 2024. The largest group is 65 to 74, with 355 patients. 75% of them have high cholesterol, and 71% have high blood pressure. Their average risk score is 0.87, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Abraham Winkelstein's median patient age at 66, with 49% women.

In 2024, Abraham Winkelstein wrote 1,174 Medicare Part D claims for 392 patients. 89% of them were for generic drugs. CMS names the drug for 1,057 of them, across 18 drugs with 11 or more claims each, at $133,671 in total drug cost. In 2023, CMS named 611 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Abraham Winkelstein for performance year 2024, reported individually. Abraham Winkelstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 103 procedures of colonoscopy by Abraham Winkelstein, more than 80% of the clinicians it reports for that procedure.

Dmand AI links 27 papers to Abraham Winkelstein. The most frequent topics are T-Lymphocytes, Immunoglobulin G and Lymphocyte Activation. Abraham Winkelstein has published most often in Am J Hematol. Abraham Winkelstein's most frequent co-authors are Franklin A. Bontempo, Margaret V. Ragni, MD and Stephan R. Targan, MD.

CMS Open Payments shows 2 general payments to Abraham Winkelstein from 2 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. CONMED Corporation paid the most, $52.

Dmand AI lists 1 award for Abraham Winkelstein, most recently CMS Stage 1 EHR in 2013.

Abraham Winkelstein graduated from Georgetown University School Of Medicine in 1991.

Abraham Winkelstein is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.